Prostate Cancer

Prostate Cancer
2024-11-20T07:09:05.870Z

FL-020-001

FL-020-001
Prostate cancer

A First-in-human, Phase 1 Dose Escalation and Expansion Study evaluating the Safety, Tolerability and Anti-tumor Activity of [ 225Ac]Ac-FL-020, an anti-PSMA Radioconjugate (RDC), in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

A First-in-human, Phase 1 Dose Escalation and Expansion Study evaluating the Safety, Tolerability and Anti-tumor Activity of [ 225Ac]Ac-FL-020, an anti-PSMA Radioconjugate (RDC), in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

Trial overview

Clinical Area

Theranostics

Disease / Condition

Prostate

Study Phase

I

GenesisCare Location(s)
Murdoch (Oncology)
location pin icon

St John of God Murdoch Hospital, 100 Murdoch Drive, Murdoch, WA, 6150, Australia

phone icon (08) 9366 1500 email icon receptiononcologymurdoch@genesiscare.com
WA
Murdoch (Oncology)
Principal Investigator(s)
Nuclear Medicine Physician

A/Prof. Joe Cardaci

MBBS, FRACP, AANNMS

A/Prof. Joe Cardaci
location pin icon

Murdoch (Oncology)

View Profile
Profile Image - A/Prof. Joe Cardaci

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.